Literature DB >> 6840823

Abnormal red blood cell ion transport and hypertension. The People's Gas Company study.

M Trevisan, D Ostrow, R Cooper, K Liu, S Sparks, A Okonek, E Stevens, J Marquardt, J Stamler.   

Abstract

A population-based survey of 134 white men, recruited from the Chicago People's Gas Company labor force, was carried out to examine the association between sodium-lithium (Na-Li) countertransport and hypertension. Of the 134 participants in this industry-sponsored periodic health examination, 64 were normotensive and 70 were either taking antihypertensive medications or had a systolic pressure greater than or equal to 140 or a diastolic pressure greater than or equal to 90 mm Hg. The hypertensives were older and more overweight. Countertransport was significantly higher in hypertensives than in normotensives. Among the three subgroups of hypertensives--untreated, borderline (140/90 to 160/95 mm Hg), untreated definite (over 160/95 mm Hg), and treated--an increase in countertransport was consistently observed, significant for the latter two groups. The relationship between countertransport and hypertension was independent of overweight, with countertransport being significantly related to both blood pressure and overweight. Altered ion transport may play an important role in the etiology and/or pathophysiology of hypertension.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840823     DOI: 10.1161/01.hyp.5.3.363

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  4 in total

1.  Changes in sodium-lithium countertransport correlate with changes in triglyceride levels and body mass index over 2 1/2 years of follow-up in Utah.

Authors:  S C Hunt; R R Williams; K O Ash
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

2.  Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment.

Authors:  D Beuckelmann; E Erdmann
Journal:  Klin Wochenschr       Date:  1986-10-31

3.  Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.

Authors:  F Galletti; P Strazzullo; R Gagliardi; M Cirillo; A Siani; R Iacone; M Mancini
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.

Authors:  M Modan; H Halkin; S Almog; A Lusky; A Eshkol; M Shefi; A Shitrit; Z Fuchs
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.